Langdon Miller
Clinical Strategist
Scientific Advisory Board
ETUBICS CORPORATION
Romania
Biography
Dr. Miller has extensive experience in the generation, analysis, presentation, and justification of drug development programs before regulatory authorities, advisory committees, investigators, investors, and business development partners. He served as Executive Vice President of Research & Development at Calistoga Pharmaceuticals, Inc. and joined the leadership team at Gilead after Gilead’s acquisition of Calistoga in 2011. He served as a Director of Pharmacia LLC. Previous to his experience at Pharmacia, he served as a Senior Investigator at the National Cancer Institute (NCI) where he provided strategic direction for NCI-sponsored trials.
Research Interest
clinical drug development
